Search Results - Cabrera-Gálvez, C.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    P22.04 Prospective Validation of an Eight Gene mRNA Signature in Plasma for the Diagnosis of Early Stage Lung Cancer

    P22.04 Prospective Validation of an Eight Gene mRNA Signature in Plasma for the Diagnosis of Early Stage Lung Cancer by Capitán, A. Giménez, Rubinstein, P., Rubinstein, F., Aguilar-Hernández, A., Bracht, J., Viteri, S., Cabrera-Gálvez, C., Gonzalez-Cao, M., Moya, I., Valarezo, J., Mayo-De-Las-Casas, C., Pedraz, C., Boykin, R., Warren, S., Rosell, R., Molina, M.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    MA03.01 EPICAL Trial. A Phase Ib StudyCombining Anti-Epidermal Growth Factor (EGF) Vaccination With Afatinib in EGFR-Mutant Non-Small Cell Lung Cancer

    MA03.01 EPICAL Trial. A Phase Ib StudyCombining Anti-Epidermal Growth Factor (EGF) Vaccination With Afatinib in EGFR-Mutant Non-Small Cell Lung Cancer by Abreu, D. Rodriguez, Cobo, M., Viteri, S., Aguilar-Hernández, A., Reguart, N., Gonzalez-Cao, M., Cabrera-Gálvez, C., Moya, I., Garcia-Roman, S., Codony-Servat, J., Peláez, B. García, Ariza, N. Jordana, Molina-Vila, M.A., D'Hondt, E., Rosell, R.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    OA01.08 Clinical Response to Tepotinib According to Circulating Tumor (ct)DNA Biomarkers in Patients with Advanced/Metastatic NSCLC with High-level MET Amplification (METamp) Detected by Liquid Biopsy (LBx)

    OA01.08 Clinical Response to Tepotinib According to Circulating Tumor (ct)DNA Biomarkers in Patients with Advanced/Metastatic NSCLC with High-level MET Amplification (METamp) Detec... by Le, X., Paz-Ares, L.G., Van Meerbeeck, J., Viteri, S., Cabrera-Galvez, C., Baz, D.V., Kim, Y.-C., Kang, J.-H., Stroh, C., Juraeva, D., Bruns, R., Otto, G., Johne, A., Paik, P.K.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: